XML 84 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Net Sales and Profit, by Segment Net sales and profit by reportable segment for the years ended December 31, 2023, 2022 and 2021 are as follows:
 Years Ended December 31,
Dollars in thousands202320222021
Segment Net Sales
Codman Specialty Surgical$1,058,993 $1,019,564 $1,025,232 
 Tissue Technologies482,580 538,102 517,216 
Total revenues$1,541,573 $1,557,666 $1,542,448 
Segment Profit
Codman Specialty Surgical$450,530 $417,873 $439,471 
Tissue Technologies134,048 233,802 228,199 
Segment profit584,578 651,675 667,670 
Amortization(12,376)(13,882)(16,914)
Corporate and other(460,676)(398,873)(453,526)
Operating income$111,526 $238,920 $197,230 
Schedule of Geographic Revenue, by Area Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
Dollars in thousands
United States(1)
EuropeAsia PacificRest of the WorldConsolidated
Total revenue, net:
2023$1,100,730 $165,221 $193,096 $82,526 $1,541,573 
20221,126,810 170,903 176,477 83,476 1,557,666 
20211,089,526 191,327 182,034 79,561 1,542,448 
Total long-lived assets:
2023$481,508 $51,730 $19,842 $1,497 $554,577 
2022440,223 60,857 12,975 2,721 516,776